Arrowhead Pharmaceuticals Inc (LTS:0HI3)
$ 20.17 0.04 (0.2%) Market Cap: 2.56 Bil Enterprise Value: 2.24 Bil PE Ratio: 0 PB Ratio: 7.54 GF Score: 51/100

Arrowhead Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript

Jun 12, 2023 / 07:20PM GMT
Release Date Price: $35.31
Madhu Sudhan Kumar
Goldman Sachs Group, Inc., Research Division - Former Research Analyst

Hi, everyone. Thanks for joining us at the first day of the Goldman Sachs Global Healthcare Conference here in sunny beautiful Southern California. I don't want to judge Chris, but he came all this way, and it's raining and cold.

We're required to make certain disclosures in public appearances about Goldman Sachs' relationships with companies that we discuss. The disclosures relate to investment banking relationships, compensation received or 1% or more ownership. We're prepared to read aloud disclosures for any issuer during the sessions upon your request. However, these disclosures are available in our most recent reports available to U.S. clients on our firm's portal. In addition, updates to those disclosures are available by ticker on the firm's public website at www.gs.com/research/hedge.html.

Goldman Sachs agrees to host this conference on the basis that no third-party speaker will provide confidential or material

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot